Manulife (Manufacturers Life Insurance)’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.54M Sell
20,941
-30,036
-59% -$2.2M ﹤0.01% 1617
2025
Q1
$5.82M Buy
50,977
+1,218
+2% +$139K 0.01% 1105
2024
Q4
$2.51M Sell
49,759
-1,237
-2% -$62.3K ﹤0.01% 1472
2024
Q3
$2.36M Buy
50,996
+2,216
+5% +$103K ﹤0.01% 1491
2024
Q2
$1.58M Buy
48,780
+932
+2% +$30.3K ﹤0.01% 1585
2024
Q1
$1.21M Buy
47,848
+5,240
+12% +$132K ﹤0.01% 1755
2023
Q4
$1.38M Sell
42,608
-703
-2% -$22.8K ﹤0.01% 1644
2023
Q3
$1.18M Buy
43,311
+10,073
+30% +$274K ﹤0.01% 1645
2023
Q2
$740K Sell
33,238
-1,742
-5% -$38.8K ﹤0.01% 1813
2023
Q1
$758K Buy
34,980
+73
+0.2% +$1.58K ﹤0.01% 1763
2022
Q4
$709K Buy
34,907
+353
+1% +$7.17K ﹤0.01% 1782
2022
Q3
$886K Sell
34,554
-553
-2% -$14.2K ﹤0.01% 1659
2022
Q2
$835K Sell
35,107
-1,787
-5% -$42.5K ﹤0.01% 1729
2022
Q1
$831K Sell
36,894
-12,253
-25% -$276K ﹤0.01% 1857
2021
Q4
$973 Sell
49,147
-920
-2% -$18 ﹤0.01% 1841
2021
Q3
$985K Sell
50,067
-5,063
-9% -$99.6K ﹤0.01% 1850
2021
Q2
$1.21M Sell
55,130
-30
-0.1% -$660 ﹤0.01% 1876
2021
Q1
$1.31M Sell
55,160
-3,302
-6% -$78.5K ﹤0.01% 1742
2020
Q4
$1.53M Buy
58,462
+2,466
+4% +$64.5K ﹤0.01% 1630
2020
Q3
$975K Sell
55,996
-1,675
-3% -$29.2K ﹤0.01% 1673
2020
Q2
$966K Sell
57,671
-3,539
-6% -$59.3K ﹤0.01% 1636
2020
Q1
$728K Buy
61,210
+3,352
+6% +$39.9K ﹤0.01% 1651
2019
Q4
$700K Sell
57,858
-238,019
-80% -$2.88M ﹤0.01% 1861
2019
Q3
$4.31M Buy
295,877
+234,219
+380% +$3.42M ﹤0.01% 1206
2019
Q2
$687K Sell
61,658
-282,494
-82% -$3.15M ﹤0.01% 1855
2019
Q1
$4.04M Buy
344,152
+314
+0.1% +$3.69K ﹤0.01% 1272
2018
Q4
$4.59M Sell
343,838
-44,276
-11% -$592K 0.01% 1177
2018
Q3
$5.44M Buy
388,114
+52,083
+15% +$730K 0.01% 1212
2018
Q2
$5.28M Buy
336,031
+45,040
+15% +$708K 0.01% 1233
2018
Q1
$4.79M Buy
290,991
+54,263
+23% +$893K 0.01% 1242
2017
Q4
$4.28M Buy
236,728
+56,754
+32% +$1.02M ﹤0.01% 1270
2017
Q3
$3.47M Sell
179,974
-1,440
-0.8% -$27.8K ﹤0.01% 1288
2017
Q2
$2.14M Buy
181,414
+121,292
+202% +$1.43M ﹤0.01% 1428
2017
Q1
$658K Buy
60,122
+7,114
+13% +$77.9K ﹤0.01% 1997
2016
Q4
$385K Sell
53,008
-932
-2% -$6.77K ﹤0.01% 2291
2016
Q3
$351K Buy
53,940
+103
+0.2% +$670 ﹤0.01% 2325
2016
Q2
$294K Buy
53,837
+9,232
+21% +$50.4K ﹤0.01% 2406
2016
Q1
$191K Buy
44,605
+937
+2% +$4.01K ﹤0.01% 2626
2015
Q4
$217 Buy
43,668
+1,227
+3% +$6 ﹤0.01% 2597
2015
Q3
$159 Hold
42,441
﹤0.01% 2835
2015
Q2
$255 Buy
42,441
+773
+2% +$5 ﹤0.01% 2656
2015
Q1
$233 Buy
41,668
+313
+0.8% +$2 ﹤0.01% 2619
2014
Q4
$124 Buy
41,355
+1,435
+4% +$4 ﹤0.01% 2966
2014
Q3
$107 Buy
39,920
+37,913
+1,889% +$102 ﹤0.01% 3064
2014
Q2
$6K Sell
2,007
-43,742
-96% -$131K ﹤0.01% 3483
2014
Q1
$200 Buy
45,749
+4,341
+10% +$19 ﹤0.01% 2716
2013
Q4
$133 Buy
41,408
+36,013
+668% +$116 ﹤0.01% 2953
2013
Q3
$9 Sell
5,395
-1,505
-22% -$3 ﹤0.01% 3269
2013
Q2
$12K Buy
+6,900
New +$12K ﹤0.01% 3158